| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AJOG.2015.09.078 |
| P698 | PubMed publication ID | 26429521 |
| P50 | author | Munther A. Khamashta | Q73418907 |
| P2093 | author name string | B J Hunt | |
| E Talavera-Garcia | |||
| G Lliso | |||
| M J Cuadrado | |||
| S Sciascia | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | human pregnancy | Q11995 |
| pregnancy outcome | Q66057507 | ||
| hydroxychloroquine | Q421094 | ||
| P304 | page(s) | 273.e1-273.e8 | |
| P577 | publication date | 2015-09-28 | |
| P1433 | published in | American Journal of Obstetrics and Gynecology | Q4744256 |
| P1476 | title | The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies. | |
| P478 | volume | 214 |
| Q96304889 | An update on the management of antiphospholipid syndrome |
| Q64046338 | Antiphospholipid syndrome |
| Q91390119 | Antiphospholipid syndrome - an update |
| Q41915133 | Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome |
| Q54218397 | Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. |
| Q38818425 | Current status and future prospects for the treatment of antiphospholipid syndrome |
| Q47982275 | Diagnosis and management of the antiphospholipid syndrome |
| Q38654271 | Do adverse pregnancy outcomes contribute to accelerated cardiovascular events seen in young women with systemic lupus erythematosus? |
| Q33731711 | EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome |
| Q38782057 | Emerging Therapies in Antiphospholipid Syndrome |
| Q47552842 | Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births |
| Q90115791 | Idiopathic Normal Pressure Hydrocephalus - What We Know |
| Q87866782 | Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era |
| Q64910478 | Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults. |
| Q93060997 | Managing antiphospholipid syndrome in pregnancy |
| Q39198671 | Pathogenesis and management of antiphospholipid syndrome |
| Q90115787 | Pregnancy Management in Women with Antiphospholidic Syndrome |
| Q38891094 | Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy. |
| Q96686028 | Prevalence of hydroxychloroquine retinopathy using 2018 Royal College of Ophthalmologists diagnostic criteria |
| Q55004116 | Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies. |
| Q38866356 | Systemic lupus erythematosus: still a challenge for physicians |
| Q45873335 | The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies |
| Q48612768 | The first genome-wide association study identifying new susceptibility loci for obstetric antiphospholipid syndrome |
| Q93020058 | The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS |
| Q93047783 | Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies |
Search more.